Manhattan Scientifics Inc MHTX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $503,352.96
- Volume/Avg
- 110,200 / 519,874
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Manhattan Scientifics Inc is a company operating as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in the areas of nano-technologies and nano-medicines. The company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. Its current focus is on the development of nanomaterials through the acquisition of Metallicum.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- http://www.mhtx.com
Valuation
|
Metric
|
MHTX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
MHTX
Financial Strength
|
Metric
|
MHTX
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.03 |
Interest Coverage | — |
Quick Ratio
MHTX
Profitability
|
Metric
|
MHTX
|
|---|---|
Return on Assets (Normalized) | −168.65% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MHTX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Crzxtjdh | Xyhps | $183.1 Bil | |||
| Stryker Corp
SYK
| Vynmmbsh | Vbr | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Jmzbgcm | Rfjppzy | $109.2 Bil | |||
| Medtronic PLC
MDT
| Rcrtkwjr | Cxbsqdx | $100.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Xzqndjjcm | Vfcwd | $36.0 Bil | |||
| DexCom Inc
DXCM
| Rjbfcpdznv | Tfm | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Gvmntdzl | Scpkkl | $24.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Fchvnkfts | Zxk | $22.8 Bil | |||
| Steris PLC
STE
| Mdgdchv | Lwcwlf | $22.5 Bil | |||
| Align Technology Inc
ALGN
| Tvbmbrj | Qpsdq | $17.0 Bil |